BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8877708)

  • 1. Allogeneic peripheral blood progenitor cells: current status and future directions.
    Dreger P; Glass B; Uharek L; Schmitz N
    J Hematother; 1996 Aug; 5(4):331-7. PubMed ID: 8877708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enrichment of G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation by negative selection.
    Dreger P; Steinmann J; Drost R; Eckstein V; Suttorp M; Müller-Ruchholtz W; Löffler H; Schmitz N
    Prog Clin Biol Res; 1994; 389():407-13. PubMed ID: 7535449
    [No Abstract]   [Full Text] [Related]  

  • 3. Allogeneic transplantation of positively selected peripheral blood CD34+ progenitor cells from matched related donors.
    Finke J; Brugger W; Bertz H; Behringer D; Kunzmann R; Weber-Nordt RM; Kanz L; Mertelsmann R
    Bone Marrow Transplant; 1996 Dec; 18(6):1081-6. PubMed ID: 8971376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation of resistant or relapsing acute leukemias.
    Rambaldi A; Viero P; Bassan R; Buelli M; Rossi A; Bellavita P; Spinelli O; Amaru R; Micheletti M; Borleri G; Cortelazzo S; Comotti B; Barbui T
    Leukemia; 1996 May; 10(5):860-5. PubMed ID: 8656684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single leukapheresis products collected from healthy donors after the administration of granulocyte colony-stimulating factor contain ten-fold higher numbers of long-term reconstituting hematopoietic progenitor cells than conventional bone marrow allografts.
    Theilgaard-Mönch K; Raaschou-Jensen K; Andersen H; Russell CA; Vindeløv L; Jacobsen N; Dickmeiss E
    Bone Marrow Transplant; 1999 Feb; 23(3):243-9. PubMed ID: 10084255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic marrow reconstitution using peripheral blood stem cells: the dawn of a new era.
    Lane TA
    Transfusion; 1996 Jul; 36(7):585-9. PubMed ID: 8701452
    [No Abstract]   [Full Text] [Related]  

  • 7. Cellular mechanism for granulocyte-colony stimulating factor in the prevention of graft-versus-host disease in combined bone marrow and peripheral blood transplantation for hematological malignancies: the composition in collection.
    Zhang C; Zhang X; Chen XH
    Transfus Apher Sci; 2013 Feb; 48(1):3-9. PubMed ID: 23279971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of G-CSF or GM-CSF mobilized peripheral blood progenitor cells (PBPC) alone or to augment marrow as hematologic support of single or multiple cycle high-dose chemotherapy.
    Elias AD; Ayash L; Tepler I; Wheeler C; Schwartz G; Mazanet R; Schnipper L; Frei E; Antman K
    J Hematother; 1993; 2(3):377-82. PubMed ID: 7522891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primed marrow for autologous and allogeneic transplantation: a review comparing primed marrow to mobilized blood and steady-state marrow.
    Elfenbein GJ; Sackstein R
    Exp Hematol; 2004 Apr; 32(4):327-39. PubMed ID: 15050742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter?
    Körbling M; Anderlini P
    Blood; 2001 Nov; 98(10):2900-8. PubMed ID: 11698269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mobilization of peripheral blood progenitor cells for allogeneic transplantation.
    Teshima A; Harada M
    Cytokines Cell Mol Ther; 1997 Jun; 3(2):101-14. PubMed ID: 9287249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term engraftment, graft-vs.-host disease, and immunologic reconstitution after experimental transplantation of allogeneic peripheral blood cells from G-CSF-treated donors.
    Pan L; Bressler S; Cooke KR; Krenger W; Karandikar M; Ferrara JL
    Biol Blood Marrow Transplant; 1996 Oct; 2(3):126-33. PubMed ID: 9199755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced antileukemic activity of allogeneic peripheral blood progenitor cell transplants following donor treatment with the combination of granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF) in a murine transplantation model.
    Hartung G; Zeis M; Glass B; Dreger P; Steinmann J; Schmitz N; Uharek L
    Bone Marrow Transplant; 2003 Jul; 32(1):49-56. PubMed ID: 12815478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryopreservation of hematopoietic stem/progenitor cells for therapeutic use.
    Watt SM; Austin E; Armitage S
    Methods Mol Biol; 2007; 368():237-59. PubMed ID: 18080475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell processing protocol for allogeneic peripheral blood stem cells mobilized by granulocyte colony-stimulating factor.
    Suzue T; Kawano Y; Takaue Y; Kuroda Y
    Exp Hematol; 1994 Aug; 22(9):888-92. PubMed ID: 7520392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial.
    Lonial S; Akhtari M; Kaufman J; Torre C; Lechowicz MJ; Flowers C; Sinha R; Khoury HJ; Langston AA; Waller EK
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):460-7. PubMed ID: 23201472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic peripheral blood progenitor cell transplantation: analysis of short-term engraftment and acute GVHD incidence in 33 cases. allo-PBPCT Spanish Group.
    Urbano-Ispizua A; Solano C; Brunet S; Hernández F; Sanz G; Alegre A; Petit J; Besalduch J; Vivancos P; Díaz MA; Moraleda JM; Carreras E; Ojeda E; de la Rubia J; Benet I; Domingo-Albós A; García-Conde J; Rozman C
    Bone Marrow Transplant; 1996 Jul; 18(1):35-40. PubMed ID: 8831993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A pilot study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for malignant hematological diseases].
    Chen Y; Huang X; Xu L; Liu D; Zhang Y; Ren H; Guo N; Lu D
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1306-9. PubMed ID: 12509932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human granulocyte colony-stimulating factor can mobilize sufficient amounts of peripheral blood stem cells in healthy volunteers for allogeneic transplantation.
    Matsunaga T; Sakamaki S; Kohgo Y; Ohi S; Hirayama Y; Niitsu Y
    Bone Marrow Transplant; 1993 Feb; 11(2):103-8. PubMed ID: 7679596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.